Treatment-Resistant Depression (TRD) is a challenging form of Major Depressive Disorder (MDD) that doesn’t respond to standard treatments. Diagnosing TRD is complicated by factors like pseudo-resistance and comorbidities, making it essential to explore advanced therapies. This webinar offers practical strategies about how healthcare providers can improve outcomes for individuals living with TRD.

In this webinar, you will hear from our speakers Ben Moy, Casey McCagh and Kristin clemens on:

  • Understanding the complexities of Treatment-Resistant Depression (TRD). Participants will gain a comprehensive understanding of the challenges in diagnosing TRD, including recognizing pseudo-resistance and managing comorbidities that complicate treatment outcomes.
  • Exploring novel therapies for TRD. Attendees will learn about cutting-edge treatment options for TRD and understand their mechanisms of action, benefits, and potential side effects.
  • Implementing best practices for prior authorization management. Participants will be equipped with strategies to effectively manage prior authorizations for novel TRD therapies, ensuring timely access to treatment and minimizing administrative burdens.
New call-to-action